Treatment of Viral Hepatitis in Children

Archives of Medical Research

Volumn 38, Issue 6, 2007, Pages 702-710

  Heller, Solange ^a   Valencia Mayoral, Pedro ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Chronic hepatitis in children; HBC infection; HBeAg seroconversion; HBV infection; Interferon alpha; lamivudine

Indexed keywords

ADEFOVIR; ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; ALPHA2B INTERFERON; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; INTERFERON; LAMIVUDINE; PEGINTERFERON; PEGINTERFERON ALPHA2A; PLACEBO; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN;

CHRONIC LIVER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE TRANSMISSION; FOLLOW UP; HEALTH CARE COST; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LIVER TRANSPLANTATION; MONOTHERAPY; MUTATION; REVIEW; RISK; VACCINATION; VIRUS HEPATITIS; VIRUS REPLICATION;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; HEPATITIS B, CHRONIC; HEPATITIS C; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; INTERFERON-ALPHA; NUCLEIC ACID SYNTHESIS INHIBITORS;

EID: 34347265600     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.09.005     Document Type: Review

References (76)

1. Heathcote E.J., and Feld J.J. Hepatitis caused by other viruses. In: Feldman M., Friedman L.S., and Brandt L.J. (Eds). Sleisenger Fordtran's Gastrointestinal and Liver disease. Pathophysiology/Diagnosis/Management, 8th ed, Vol 2 (2006), Saunders Elsevier, Philadelphia, PA 1719-1729
2. Elisofon S.A., and Jonas M.M. Hepatitis B and C in children: current treatment and future strategies. Clin Liver Dis 10 (2006) 133-148
3. Shepard C., Finelli L., and Alter M. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5 (2005) 558-567
4. Granovsky M.O., Minkoff H.L., Tess B.H., Waters D., Hatzakis A., Devoid D.E., et al. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 102 (1998) 355-359
5. Bortolotti F., Resti M., Giacchino R., Crivellaro C., Zancan L., Azzari C., et al. Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. J Pediatr 133 (1998) 378-381
6. Mok J., Pembrey L., Toyo P.-A., and Newell M.-L. When does mother to child transmission of hepatitis C virus occur?. Arch Dis Fetal Neonatal Ed 90 (2005) F156-F160
7. Schuval S., Van Dyke R.B., Lindsey J.C., Palumbo P., Mofenson L.M., Oleske J.M., et al. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a log-term follow-up protocol. Arch Pediatr Adolesc Med 158 (2004) 1007-1013
8. Buster E.H., and Janssen H.L. Antiviral treatment for chronic hepatitis B virus infection. Immune modulation or viral suppression?. Neth J Med 175 (2006) 175-185
9. Asselah T., Cateinau C., and Marcellin P. Treatment of chronic hepatitis B. Presse Med 35 (2006) 327-344
10. Ocama P., Opio C.K., and Lee W.M. Hepatitis B virus infection: current status. Am J Med 118 (2005) 1413e15-1413e22
11. Hsu H.Y., Chang M.H., Lee C.Y., Chen J.S., Hsu H.C., and Chen D.S. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 15 (1992) 382-386
12. Bortolotti F., Wirth S.M., Crivellaro C., Alberti A., Martine U., and Moliner L. Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e Antigen to antibody seroconversion. J Pediatr Gastroenterol 22 (1996) 170-174
13. Chang M.H., Hsu H.Y., Hsu H.C., Ni Y.H., Chen J.S., and Chen D.S. The significance of spontaneous hepatitis B e antigen seroconversion in childhood with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 22 (1995) 1389-1392
14. Vogt M., Lang T., Frösner G., Klingler C., Sendl A.F., Zeller A., et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. NEJM 341 (1991) 866-870
15. Casiraghi M.A., De Paschale M., Romanò L., Biffi R., Assi A., Binelli G., et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 39 (2004) 912-913
16. Garcia-Monzon C., Jara P., Fernandez-Bermejo M., Hierro L., Frauca E., Camarena C., et al. Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology 28 (1998) 1696-1701
17. Guido M., Rugge M., Jara P., Hierro L., Giacchino R., Larraugi J., et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 115 (1998) 1525-1529
18. Badizadegan K., Jonas M.M., Ott M.J., Nelson S.P., and Perez-Atayde A.R. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 28 (1998) 1416-1423
19. Murray K.F., Finn L.S., Taylor S.L., Seidel K.D., and Larson A.M. Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection. J Pediatr Gastroenterol Nutr 41 (2005) 634-638
20. Castellino S., Lensing S., Riely C., Rai S.N., Davila R., Hayden R.T., et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer; an update of the St. Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 103 (2004) 2460-2466
21. Cesaro S., Petris M.G., Rossetti F., Cusinato R., Pipan C., Guido M., et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90 (1997) 1315-1320
22. Bortolotti F., Resti M., Marcellini M., Giacchino R., Verucchi G., Nebbia G., et al. Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome. Gut 54 (2005) 852-857
23. Seeff L.B., and Hooffnagle J.H. The National Institutes of Health Consensus Development Conference: Management of Hepatitis C 2002. Clin Liver Dis 7 (2003) 261-287
24. Gismondi M.I., Turazza E., Grinstein S., Galoppo M.C., and Preciado M.V. Hepatitis C virus infection in infants and children from Argentina. J Clin Microbiol 42 (2004) 1199-1202
25. Pembrey L., Newell M.-L., Tovo P.-A., and EPHN Collaborators. The management of HCV infected pregnant women and their children. European paediatric HCV network. J Hepatol 43 (2005) 515-525
26. England K., Pembrey L., Tovo P.A., Newell M.L., and European Paediatric HCV Network. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatr 94 (2005) 44-50
27. White F.V., and Dehner P.L. Viral diseases of the liver in children: diagnostic and differential diagnostic considerations. Pediatr Pathol Develop Pathol (2004) 552-567
28. Bedossa P., Paradis V., and Lazaure T. Hépatites chroniques virales. In: Reynés M. (Ed). La biopsie hépatique en pathologie non tumorale du foie. Groupe Metavir (2000), Elsevier, Paris, France 24-39
29. Desmet V., Gerber M., Hoofnagle J.H., Manns M., and Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19 (1994) 1513-1520
30. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., Kiernan T.W., et al. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic hepatitis. Hepatology 1 (1981) 431-435
31. Ishak K., Baptista L., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histology grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
32. Lok A.S.F. The maze of treatments for hepatitis B. N Engl J Med 352 (2005) 2743-2746
33. Lok A.S., and McMahon B.J. Chronic hepatitis B: update of recommendations. Hepatology 39 (2004) 857-861
34. Jara P., and Bortolotti F. Interferon-α treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediatr Gastroenterol Nutr 29 (1999) 163-170
35. Jonas M.M. Treatment of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr 43 (2006) S56-S60
36. Ruiz-Moreno M., Rua M.J., Molina J., Moraleda G., Moreno A., García-Aguado J., et al. Prospective randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology 13 (1991) 1035-1039
37. Narkewicz M.R., Smith D., Silverman A., Vierling J., and Sokol R. Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment. J Pediatr 127 (1995) 815-818
38. Sokal E.M., Conjeevaram H.S., Roberts E.A., Alvarez F., Bern E.M., Goyens P., et al. Interferon alpha therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 114 (1998) 988-995
39. Özen H., Koçak N., Yüce A., and Gürakan F. Retreatment with higher-dose interferon alpha in children with chronic hepatitis B infection. Ped Infect Dis J 18 (1999) 694-697
40. Johnson M.A., Moore K.H., Yuen G.J., Bye A., and Pakes G.E. Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet 36 (1999) 41-66
41. Dienstag J.L., Schiff E.R., Wright T.L., Perrillo R.P., Hann H.W., Goodman Z., et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 341 (1999) 1256-1263
42. Leung W.A.J., Lai C.L., Chang T.T.L., Guan R., Chuan-Mo L., Keng-Yeen N.G., et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 33 (2001) 1527-1532
43. Sokal E.M., Roberts E.A., Mieli-Vergani G., McPhillips P., Johnson M., Barber J., et al. A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B. Antimicrob Agents Chemother 44 (2000) 590-597
44. Koçak N., Saltik I.N., Özen H., Yüce A., and Gürakan F. Lamivudine treatment for children with interferon refractory chronic hepatitis B. Hepatology 31 (2000) 545-546
45. Jonas M.M., Kelley D.A., Mizerski J., Badia I., Areias J., Schwarz K., et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 346 (2002) 1706-1713
46. Liberek A., Szaflarska-Popawska A., Korzon M., Luczak G., Gora-Gor M., Los-Rycharska E., et al. Lamivudine therapy for children with chronic hepatitis B. World J Gastroenterol 12 (2006) 2412-2416
47. Sokal E.M., Kelly D.A., Mizerski J., Badia I.B., Arelas J.A., Schwarz K.B., et al. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 43 (2006) 225-232
48. Schalm S.W., Heathcote J., Cianciara J., Farrell G., Sherman M., Willems B., et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomized trail. Gut 46 (2000) 562-568
49. Sokucu S., Gokce S., Suoglu O.D., Emiroglu H., and Ceikbas U. Comparison of interferon monotherapy with interferon-lamivudine combination treatment in children with chronic hepatitis B. Indian J Gastroenter 25 (2006) 136-139
50. D'Antiga L., Marion A.W., Atkins M., Moorat A., Vergani D., et al. Combined lamivudine/interferon-α treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study. J Pediatr 148 (2006) 228-233
51. Chang T.T., Gish R.G., de Man R., Gadano A., Sollano J., Chao Y.C., et al. A comparison of entcavir and lamivudine for HBe Ag-positive chronic hepatitis B. N Eng J Med 354 (2006) 1001-1010
52. Lai C.J., Shouval D., Lok A.S., Chang T.T., Cheinquer H., Goodman Z., et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 354 (2006) 1011-1020
53. Vassiliadis T., Patsiaoura K., Tziomalos K., Gkiourtzis T., Giouleme O., Grammatikos N., et al. Pegylated IFN-alpha 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B. World J Gastroenterol 12 (2006) 2417-2422
54. Sarin S.K., Kuman M., Hissar S., and Sharma B.C. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment. Hepatobiliary Pancreat Dis Int 5 (2006) 374-380
55. von Zonneveld M., Zondervan P.E., Cakaloglu Y., Simon C., Akarca U.S., So T.M., et al. Peg-interferon improves liver histology in patients with HBe-Ag positive chronic hepatitis B: no additional benefit of combination with lamivudine. Liver Int 26 (2006) 399-405
56. Ben-Ari Z., Broida E., Kittai Y., Chagnac A., and Tur-Kaspa R. An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation. Am J Gastroenterol 95 12 (1999) 3579-3583
57. Shapira R., Mor E., Bar-Nathan N., Sokal E.M., Tur-Kaspa R., Dinari G., et al. Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. Transplantation 72 (2001) 333-336
58. Yan M.L., Yan L.N., Li B., Zeng Y., Wen T.F., Wang W.T., et al. Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation. Hepatobiliary Pancreat Dis Int 5 (2006) 360-363
59. Mutimer D. Review article: hepatitis B and liver transplantation. Aliment Pharmacol Ther 23 (2006) 1031-1041
60. Jacobson K.R., Murray K., Zellos A., and Schwarz K.B. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol 34 (2002) 52-58
61. Bortolotti F., Iorio R., Nebbia G., and Marcellini M. Interferon treatment in children with chronic hepatitis C: long-lasting remission in responders, and risk for disease progression in non-responders. Dig Liver Dis 37 (2005) 336-341
62. Hadziyannis S.J., Sette Jr. H., Morgan T.R., Balan V., Diago M., Marcellin P., et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis. N Engl J Med 140 (2004) 346-355
63. Sangik O., and Afdhal N. Antiviral therapy for treatment naïve patients with hepatitis C virus. Infect Dis Clin North Am 20 (2006) 99-113
64. Gonzalez-Peralta R., Haber B.A., and Jonas M.M. Interferon alfa 2b in combination with ribavirin for the treatment of chronic hepatitis C in children. Hepatology 36 (2002) 311A
65. Wirth S., Lang T., Gehring S., and Gerner P. Recombinant alpha-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 36 (2002) 1280-1284
66. Urganci N., Gulec S., Arapoglu M., Vural S., and Nuhoq A. The effect of ribavirin on bone density in patients with chronic hepatitis C treated with interferon-ribavirin therapy. J Pediatr Gastroenterol Nutr 41 (2005) 650-652
67. Ward R.P., and Kugelmas M. Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C. Am Fam Physician 72 (2005) 655-662
68. Schwarz K.B., Mohan P., Narkewicz M.R., et al. The safety, efficacy and pharmacokinetics of peginterferon alfa-2a (40kD) in children with chronic hepatitis C. Gastroenterology 124 Suppl 1 (2003) A700
69. Kowala-Piaskowska A., Figlerowicz M., Mozer-Lisewska I., and Sluzewski W. Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C. Przegl Epidemiol 59 (2005) 491-499
70. Wirth S., Peiper-Boustani H., Lang T., et al. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 41 (2005) 1013-1018
71. Murray K., Barton B., and Gonzalez-Peralta R. Development of a multi-center, randomized controlled trial for children with chronic hepatitis C (PEDS-C). J Pediatr Gastroenterol 41 (2005) 524
72. Lebensztejn D.M., Sobanjec-Lotowska M.E., Kaczmarski M., Voelker M., and Schuppan D. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol 12 (2006) 3338-3343
73. Xu Q., Xiao L., Lu X.B., Zhang Y.X., and Cai X. A randomized controlled clinical trial: Interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 12 (2006) 3434-3437
74. Ropero A.M., Danovaro-Holliday M.C., and Andrus J.K. Progress in vaccination against hepatitis B in the Americas. J Clin Virol 34 Suppl 2 (2005) S14-S19
75. Gerner P., Waltz A., Jenke A., Wintermeyer P., and Wirth S. Hepatitis B virus can be transmitted perinatally from HBsAg negative mothers. J Pediatr Gastroenterol Nutr 42 (2006) E63
76. Chang M.-H., Hadzic D., Heller S., Jonas M., Kohn I.J., Negro F., et al. Acute and chronic hepatitis: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 39 (2004) 584-D588